English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

culitic disease which is characterized by recurrent oral and genital aphtous ulcers, skin lesions, uveitis, arthritis and vasculitis.1 Thrombosis as a result of vasculitis and lower extremity deep vein involvement as the leading finding may be present. Budd-Chiari syndrome (BCS) is caused by obstruction of major hepatic veins. These patients may progress to liver failure and portal hypertension over time.2 BCS is related with BD in 5% of cases in western countries, while 9% in Turkey and 13% in Egypt.3,4 However, misdiagnosis or delay of diagnosis is common in patients with BD-related BCS.5 Some of the patients may be asymptomatic, while abdominal pain, jaundice, emesis, hepatomegaly and ascites are frequently present. In these patients, incomplete diagnostic criteria of BD should not delay the treatment. Here, we present a patient hospitalized for elevated liver enzymes and history of lower extremity thrombosis diagnosed later as BD-related BCS responding to combination therapy.

Behçet's Disease-Related Budd-Chiari Syndrome Responding to Combination of Cyclophosphamide, Rivaroxaban and Corticosteroids